Complete Up To Date Information about A180 Sterile Antimicrobial Injectable Solution.
NADA Number: 141-207 | |
| Proprietary Name |
A180® Sterile Antimicrobial Injectable Solution |
|---|---|
| Sponsor |
Pfizer, Inc. |
| Sponsor Address |
235 East 42d St. New York, NY 10017 USA |
| Ingredients |
Danofloxacin |
| Species |
Cattle, beef, excluding veal calves |
| Routes of Administration |
Subcutaneous |
| Dose Form |
Liquid (solution) |
| Drug Form |
Liquid (solution) |
| Dispensing Status |
RX |
| Patent Number |
4861779 5811130 |
| Exclusivity |
No product using danofloxacin mesylate as an active ingredient has been previously approved for use in cattle in any other application. |
| Withdrawal Time |
Cattle: 4 days before slaughter. A withdrawal time for pre-ruminating veal calves has not been established. |
|
Dosage Amount, Indications & Limitations |
522.522 Danofloxacin. Specifications: Each milliliter of solution contains 180 milligrams danofloxacin as the mesylate salt. Conditions of use: Cattle (excluding veal calves) Amount. 6 mg per kilogram of body weight by subcutaneous injection. Treatment should be repeated approximately 48 hours following the first injection. Indications: For the treatment of bovine respiratory disease (BRD) associated with Mannheimia [Pasteurella) haemolytica and Pasteurella multocida. Limitations: Animals intended for human consumption should not be slaughtered within 4 days from the last treatment. Do not use in cattle intended for dairy production. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Federal law prohibits the extra-label use of this drug in food-producing animals. |
| Tolerances |
Cattle a. Liver (the target tissue). The tolerance for parent danofloxacin (the marker residue) is 0.2 part per million (ppm). b. Muscle. The tolerance for parent danofloxacin (the marker residue) is 0.2 ppm. |